首页|基于1H-吡唑并[3,4-b]吡啶母核PI3Kδ抑制剂的设计合成

基于1H-吡唑并[3,4-b]吡啶母核PI3Kδ抑制剂的设计合成

扫码查看
恶性肿瘤严重危害人类健康与生命,磷脂酰肌醇-3激酶家族(PI3Ks)在细胞增殖、分化过程中起着重要作用,该激酶及其相关通路的其他激酶可被药物干预,是抗癌药物的热门靶点.在以往的PI3K抑制剂中,均有1H-吡唑并[3,4-b]吡啶母核,通过虚拟筛选以及合成路线设计,合成了一系列1H-吡唑并[3,4-b]吡啶类化合物,该类化合物可能对PI3Kδ具有潜在抑制作用.
Design and Synthesis of PI3Kδ Inhibitor Based on 1H-Pyrazolo[3,4-b]pyridine Structure
Malignant tumours pose a significant threat to human health and life.The Phosphatidylinositol 3-kinase(PI3Ks)family plays a pivotal role in cell proliferation and differentiation.This kinase and other kinases associated with its pathway can be targeted by phar-maceutical interventions,making them a popular target for anti-cancer drugs.Among previous PI3K inhibitors,a common 1H-pyrazolo[3,4-b]pyridine structure was identified.Through virtual screening and synthetic route design,a series of 1H-pyrazolo[3,4-b]pyridine compounds were synthesized,which may potentially inhibit PI3Kδ.

PI3K inhibitorsorganic synthesis1H-pyrazolo[3,4-b]pyridineanti-cancer drugs

田宇奇、兰明、王强、郑永胜

展开 >

中南民族大学药学院,湖北武汉 430074

PI3K抑制剂 有机合成 1H-吡唑并[3,4-b]吡啶 抗癌药

国家自然科学基金

81073208

2024

洛阳理工学院学报(自然科学版)
洛阳理工学院

洛阳理工学院学报(自然科学版)

影响因子:0.229
ISSN:1674-5043
年,卷(期):2024.34(2)
  • 18